Location of Repository

The impact of educational interventions on influenza and pneumococcal vaccination rates in primary care

By AN Siriwardena

Abstract

Background. Influenza and pneumococcal vaccinations are important therapies supported by national and international guidelines for preventing morbidity and mortality from respiratory illnesses in high-risk groups. The responsibility for delivering these vaccinations in the United Kingdom lies with primary care. Little is known about how rates of influenza and pneumococcal vaccination can be increased in high-risk groups in primary care.\ud Aim. To research methods of improving rates of influenza and pneumococcal vaccination in high-risk groups in primary care.\ud Objectives. To investigate the impact of educational interventions for primary care teams on influenza and pneumococcal vaccination rates in high-risk groups.\ud Method. The research had the following components: \ud a. Literature search examining current practice and policy in relation to influenza and pneumococcal vaccination and studies undertaken to improve performance, both in general and specifically in relation to improving adult vaccination rates. \ud b. Pilot study of targeting influenza and pneumococcal vaccination to high-risk groups in a single general practice. \ud c. Effect of audit and feedback with an information pack to primary care teams on influenza and pneumococcal vaccination in primary care: before-and-after multipractice study.\ud d. Effect of audit and feedback with an information pack to primary care teams, as part of a clinical governance programme, on influenza and pneumococcal vaccination in a primary care trust: before-and-after multipractice study.\ud e. Randomised controlled study of an educational outreach intervention partly nested within primary care trust study with audit, feedback and information (passive dissemination of guidelines and recommendations) directed at primary health care teams compared with audit feedback and information alone using multifaceted interventions to increase influenza and pneumococcal vaccine uptake in high-risk groups in primary care. \ud Results. The studies demonstrated significant improvements in influenza and pneumococcal vaccination rate in high-risk groups in primary care, showed the levels of improvement that could be expected from these types of intervention and described how primary care teams responded to direct and indirect educational interventions supported by measurement of performance.\ud Conclusions. Education to multiprofessional teams is an important method for diffusion of innovations in the highly professionalised organisations of primary care and general practice. Educators need to understand the complex nature of primary care organisations and teams, when and how education for teams is likely to be successful, the barriers to implementation of new ideas and how to address these. Education when applied appropriately can have important effects in improving health care. This is more likely to occur when careful assessments are made around the nature of the evidence, clear outcomes are sought and measured and the healthcare intervention is understood from the perspective of the patient, the healthcare team and other stakeholders

Topics: A300 Clinical Medicine
Year: 2003
OAI identifier: oai:eprints.lincoln.ac.uk:2345

Suggested articles

Preview

Citations

  1. (2000a) Framework for design and evaluation of complex interventions to r randomised trials.
  2. (2000c) Analysis of cluster randomized trials in primary care: a practical approach. doi
  3. (2002b) Researching the outcomes of educational interven
  4. (2000). 1514.3.6 Measuring change The audit was repeated in
  5. 184Table 20 Item-total statistics for pilot study ‡‡‡‡‡‡‡‡‡‡ Scale mean if item deleted Scale variance if item deleted Corrected item-total correlation Squared multiple correlation Alpha if item deleted Q1
  6. (1998). 2 Effects of influenza vaccination of health-care workers on mo 278Carrat F, Flahault A, Boussard E, Farran N, Dangoumau L, Valleron AJ
  7. 22 Pneumococcal vaccine uptake, Minster Practice 1997-1999 Criteria Standards
  8. (1995). 230CHAPTER 6 DISCUSSION nce l and related themes in the modernisation agenda of the British ain elements in the diffusion of innovations as the innovation itself and its communication over time to members of a social system (Rogers
  9. 315, 1371-1374. ding the CONSORT statement to cluster randomized trials: for discussion.
  10. 321, 1217-1219. anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 322, 654. people fail to comply with influenza vaccination? doi
  11. 351, 1283-1284. ief ol use.
  12. (1998). 4.3.4 Gathering information and strategies for change In doi
  13. (1999). 4.3.5 Data analysis and feedback Data were analysed to produce summary data, graphs and results for feedback to practices. We returned anonymised graphical feedback of performance in
  14. (1990). 4.5.10 Statistical methods Data analysis was carried out using Egret and SPSS version 10 (Norusis
  15. (2001). 4.5.11 Ethical issues A number of ethical issues were considered in relation to the study design (Hutton
  16. (2000). 4.5.3 Recruitment of practices All practices in West Lincolnshire Primary Care Trust (n=39) and Trent Focus Collaborative Research Network (n=50) were invited to participate in the study in
  17. (2000). 4.5.4 Baseline data collection The initial baseline data collection was carried out in doi
  18. (2000). 4.5.5 Randomisation Randomisation was carried out in doi
  19. (1990). 4.5.6 Intervention The intervention was an educational outreach visit by the researcher to practice teams based on the principles of academic detailing (Thomson O'Brien et al. 2000c; Soumerai and Avorn
  20. (1998). 4.5.9 Sample size Sample size was calculated with vaccination rate per practice as the primary outcome. Using preliminary data from the countywide multipractice audit of vaccination uptake conducted by Lincolnshire PCAG in
  21. (1997). 6.3.3 Supporting and developing teamwork 245of time, personnel and funding. Sometimes, the development of practice systems was informal and implicit rather than by using explicit methods to formally analyse and map the process (Plsek
  22. (2001). 6.7.2 Primary care trusts 267representation together with management on the boards of these organisations will strengthen and promote the shared agenda of primary care in delivering services (Wilkin et al.
  23. (1999). A (1999a) Methods in health service researc Ukoumunne doi
  24. A (1999b) The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. doi
  25. (2000). A framework for development and evaluation of RCTs for complex interventions to improv Merkel PA, Caputo GC
  26. A meta-analysis of randomized controlled trials. doi
  27. (1999). A new structure for quality improvement reports. Qual.Health Care 8, 76. of change in clinical practice: dissemination and implementation of clinica guidelines.
  28. (1997). A randomised intervention study to examine the effect on immunisation coverage of making infl
  29. (2001). A simulation study of doi
  30. (1998). A study of reasons for an increase in acute respiratory tract J.Epidemiol.Community
  31. (2000). A systematic review of the effect of continuing medical education De Graeve
  32. (1991). A target-based model for increasing influenza doi
  33. absent or dysfunctional spleen. Guidelines should highlight risk of Salmonella infection in sickle cell disease.
  34. (1997). Achieving guidelines for the treatment of depression in primary ortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome.
  35. (2002). Achieving national influenza vaccine targets--an tes. Commun.Dis.Public Health 5, 119-126. respiratory tract infection in adults in a general practice setting. Eur.J A technique for the measurement of attitudes.
  36. (1989). ACIP: pneumococcal polysaccharide vaccine. doi
  37. (1964). Acquiescence measurement and theory. doi
  38. (1991). Action research for educational change.' (Open University Press: Elton PJ, Panigrahi H
  39. (1999). Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the eld doi
  40. (2002). Adult pneumococcal vaccination: a review of physician and patient barriers. doi
  41. (1993). Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus The efficacy of influenza vaccina Grant J doi
  42. (1988). Ageing 21, 357-361. m rn Med
  43. and pneumococcal vaccination status in elderly outpatients. doi
  44. (1991). Antibiotic therapy, clinical features and outcome of 36 adults presenting to hospital with Jonkman JH doi
  45. (1981). Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects. doi
  46. (2000). Are pneumococcal vaccines effective. Bandol 293Moore RA, Wiffen PJ,
  47. (1999). Assessing the costs of healthcare technologies in clinical trials.
  48. ational behaviour perspective.
  49. (1993). Attitude of healthcare personnel regarding influenza immunization. Infec Watkins J doi
  50. (2000). Audit and feedback versus alternative strategies: effects on professional practice and health care o Thomson doi
  51. (1990). audit working paper 6.' (HMSO, London) Secretaries of State for Health Wales, Northern Ireland and Scotland (1989c) 'Working for patients. The health service: working for the 1990s. Cm 555.' (HMSO, London) Senge PM
  52. Bark 276increase influenza immunization rates in the elderly.
  53. (2001). Barriers to influenza influenza epidemic of 1989/90.
  54. based evaluation is interim measure of implementation.
  55. (2001). Bridging the quality chasm. doi
  56. (1999). Can small group education and peer review improve care for patients with asthma/ch doi
  57. (1994). Changing physician behavior to impro
  58. (1995). Changing physician strategies. JAMA 274, 700-705. pneumococcal vaccination of adults and elderly persons in Belgium.
  59. (2001). Changing provider behavior: an overview of systematic review Grol R doi
  60. (1999). Clinical effectiveness, policies, and practices 5.
  61. (2000). Clinical governance in primary care groups: the feasibility evidence-based performance indicators. doi
  62. (2001). Community acquired pneumonia. In 'Clinical evidence'. doi
  63. (1995). Communitywide laboratory-ba influenza surveillance focused on older persons,
  64. (1997). Comparison of three methods of recalling patients for in
  65. (1996). Computer program - word processing, database and
  66. (2001). Contamination in trials: is cluster randomisation the answer? Torgerson DJ, Roberts C doi
  67. (1998). Cooperation: the foundation of improvement.
  68. (2001). Coping with complexity: educating for capability doi
  69. (2002). Cost effectiveness of continuing professional development in health care: a critical review of the evidence. doi
  70. (1980). Cost effectiveness of vaccination against pneumococcal pneumonia. doi
  71. (2001). Cost-benefit analysis of a strategy to vaccinate healthy working Nichol KL, Baken L, Nelson A (1999a) Relation between influenza vaccination and outpa
  72. (2001). Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands. doi
  73. (2000). Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 immunization in a low-income urban population. doi
  74. (1997). Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. doi
  75. (1990). Data analysis was performed using SPSSPC version 10 (Norusis
  76. (1990). Data were analysed using SPSSPC version 10 (Norusis
  77. (2002). de Melker RA (1998c) Improving influenza
  78. (1991). Deaths in Great Britain associated with the ing
  79. (1997). Delivery of vaccines to adults: correlations with physician knowledge and patient variables. doi
  80. (1993). Design a questionnaire. doi
  81. (1997). Developing curricula to promote preventive medicine skills. The Teaching Immunization for Medical Education (TIME) Project. doi
  82. (1999). Diabetes complication Kernick DP
  83. (1992). Do knowledge and attitudes about influenza and its immunization affect the likelihood of obtaining immunization?
  84. (1998). Does CME work? An analysis of the effect of ed
  85. (1999). Econ Piyasirisilp S, Hemachudha T
  86. (1988). effect of audit and feedback on immunization delivery: a systematic review.
  87. (1993). Effect of clinical guidelines on medical practic systematic review of rigorous evaluations. doi
  88. (2000). Effect of patient reminder/recall interventions on immunization rates: A review. doi
  89. (1994). Effect of physician reminders on preventive care: meta-analysis of randomized clinical trials.
  90. effective health care. doi
  91. (1997). Effectiveness Altman DG,
  92. (1997). Effectiveness influenza vaccine in reducing hospital admissions in people with diabetes. doi
  93. (1998). Effectiveness of pneumococcal vaccine. Lancet 351, 1284-1285 1521-1525. Oppenheim Ortqvist doi
  94. (2001). Efficac pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-anal randomized trials. doi
  95. Efficacy and associated cost savings. doi
  96. (2000). Efficacy of influenza vaccine in the eld in welfare nursing homes: reduction in risks of mortality and morbidity dur influenza A (H3N2) epidemic. doi
  97. (1996). Efstratiou A
  98. (1962). entions designed to increase the utilization of evidence-based guidelines. Fam.Pract. 17 Suppl 1, S26-7) 'Promoting better health. The governments' programme for improving primary health Rogers EM
  99. (1969). Epidemic Gable
  100. (1995). Epidemiology of pneumococcal disease.' doi
  101. (1997). Evaluating healthcare policies: the case of clinical audi doi
  102. (1966). Evaluating the quality of medical care. doi
  103. (2000). Evaluation of the effectiveness of an ed Sanford JB
  104. (1994). Evaluation of the l 1, Hak E, van Essen GA, Buskens E, Stalman W, de Melker RA (1998a) Is immunising t in ealth 52,
  105. (1999). evaluations of interprofessional education.' (Learning and Teaching Support Netw Freudenstein U, Howe A
  106. (1986). Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, doi
  107. (2002). Excess winter mortality: influenza or cold stress? Observational study. doi
  108. (2000). Experimental and quasiexperimental designs for evaluating guideline implementation strategies. doi
  109. (1998). Failure to immunize the elderly: a systems problem or a statement of personal values?
  110. (1999). Family doctor advice is the main determinant of pneumococcal doi
  111. (1999). Farooqi A doi
  112. (1999). for Guidelines on Evaluation
  113. (1998). for influenza and pneumococcal vaccines.
  114. (1996). for Reviews and Dissemination doi
  115. (2001). for the Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action) (2000b) Sample size calculations for cluste
  116. (1999). General practitioners' perceptions of doi
  117. (2002). General practitioners' self ratings of skills in evidence based medicine: validation Yudkin PL,
  118. (2002). Guidelines for managing community acquired pneumonia in adults. doi
  119. (1996). Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. doi
  120. (1993). Health (2001b) 'National service framework for older people.' don) a vaccine. BMJ 313, ed that only 14% of patients were offered Mem.Fund.Q. Deodhar HA,
  121. (1996). Hispanic whites aged > or =65 years -- Los Angeles County,
  122. (1989). Immunization of elderly Fedson DS doi
  123. (1980). Impact of epidemic type A influenza in a defined adult population.
  124. (1999). Improving the health behaviours of elderly people: randomised controlled trial of a general practice education programme. doi
  125. (1996). Improving the quality of reporting of randomized controlled trials. The CONSORT statement. doi
  126. (1996). in the United Kingdom were also arguing for a change to an age based policy around this time (DiGuiseppi
  127. (1999). Incremental effectiveness of pneumococcal vaccine onia among persons aged 65 years or older. Vaccine 17, doi
  128. (1987). Inefficacy of pneumococcal vacci in a high-risk population. doi
  129. (2000). Influenza and pneumococcal vaccination: patient perceptions.
  130. (1997). Influenza and tetanus immunization. Are adults up-to-date in ru Alberta? Can.Fam.Phys Rycroft-Malone
  131. influenza immunization among seniors.
  132. (1995). Influenza vaccination in the elderly. doi
  133. (1992). Influenza vaccination.
  134. (1998). Influenza vaccine uptake distribution in England and James E
  135. (1991). Innovation in health care teams. doi
  136. Interdisciplinary education would help improve teamwork.
  137. (2002). Interventions that Sutton GC, Poole-Wilson PA
  138. (1998). Introdu quality improvement programme to primary healthcare teams. doi
  139. (1992). Investigating and dealing with publication and other biases in meta-analysis. doi
  140. Life after the postgraduate education allowance. BMJ 316, 1619-1620. statistics for epidemiology. Stone Mountain, GA., USD Inc. A study in 75 nursing and residential homes for elderly people.
  141. (1932). Lin EH, Katon WJ, Simo care: is physician education enough?
  142. Lofgren RP (1990b) Frequency of adverse reactions after influenza vaccination.
  143. (2000). Mass media interventions: effects on health services utilisation. Cochrane Database.Syst.Rev. doi
  144. (1999). McFlu". The
  145. (1987). Medical statistics on microcomputers.' doi
  146. (2000). Methods for systematic orce on Community Preventive Services.
  147. (1997). Microscopic polyangiitis after influenza vaccination.
  148. (1990). Modern vaccines. Pneumococcus and influenza. doi
  149. (2001). Modernising primary and community health services. doi
  150. (1995). Morbidity statistics from general practice. Fourth national study 1991-1992.' (HMSO,
  151. neumonia in adults in British hospitals in 1982- 1983: a survey of aetiology, mortality, prognostic factors and outcome.
  152. (2000). Neuraminidase inhibitors for nce of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in
  153. (1991). Newark Information Sharing Project: lessons for Med Pringle
  154. Nguyen-van Tam of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. doi
  155. (2001). nterventions on GP luster randomised controlled
  156. (1999). of influenza and can they be prevented? Experience from the 1989 epidemic of H3N influenza A in general practice.
  157. (1992). Opinions of family physicians and specialists on vaccination against influenza.
  158. (1950). Persistence of antibodies in human subjects injected with pneumococcal polysaccharides.
  159. (1997). Personal paper. Beliefs and evidence in changing clinical practice. BMJ W, Sacks HS, doi
  160. (1993). Pneumococcal polysaccharide vaccine efficacy. An evaluation of current man RF
  161. (1998). Pneumococcal serotypes and their clinical relevance. doi
  162. (1995). Pneumococcal vaccination, poor responders and reimmunization.' Black N
  163. (1998). Pneumococcal vaccination: perceptions of primary care physicians. doi
  164. (1990). Pneumococcal vaccination. Controve and opportunities.
  165. (1997). Pneumococcal vaccine campaign based in general practice. 000) Clinical governance in the first year - models to implement the CHD National Service Framework.
  166. (1997). Pneumococcal vaccine campaign based in general practice. Small audit show pneumococcal vaccine. doi
  167. (1993). Pneumococcal vaccine in the prevention of communityacquired pneumonia: a skeptical view of cost-effectiveness.
  168. (1982). Pneumonia and influenza deaths during epidemics: implications for prevention. doi
  169. (1997). Postgraduate education for general practitioners. doi
  170. (2001). Practices from both PCGs were invited to re-audit their influenza and pneumococcal vaccination rates in
  171. (1996). Predicting health behaviour research and practice with social cognition models.'
  172. Press: New York; London) Designing essons from an tegies. BMJ 320, 1580-1583. an ral ician 43, 50-55. e 11, 174-180. ucational intervention for general practitioners in adolescent health care: randomised controlled trial.
  173. (2000). Press: The flu news epidemic. doi
  174. (1999). Prevalence and clinical characteristics of left ventricular dysfunction among 2. doi
  175. (1996). Prevalence of antibiotic resistance in Wiselka M doi
  176. Prevalence of resistance to penicillin is higher in east London ...
  177. (2000). Preven influenza in healthy adults. Vaccine 18, 957-1030. tion and early treatment of Department of Health
  178. (1995). Preventing pneumococcal bacter case-control study.
  179. (1982). Previous hospital care as a risk factor for pneumonia Implicat Ferlie E
  180. (2000). Problem-based learning: why curricula are likely to show little effect on knowledge and clinical skills. doi
  181. (1998). Professional and practice development plans for primary care teams. doi
  182. (1999). Prognosis after community-acquired pneum doi
  183. (1998). Qual.Saf Health Car Salisbury DM
  184. (1999). Quantitative data analysis with doi
  185. (1996). r ry function in asthma. Lancet 351, 8. S Inc.: Chicago, IL) 998) g home residents.
  186. (1998). Randomised placebo-controlled crossove trial on effect of inactivated influenza vaccine on pulmona
  187. (1999). Randomized, placebo-controlled studies of J.Antimicrob.Chemother. 44 Suppl B, 23-29. prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.
  188. (2002). reactions to influenza vaccine in the elderly. A randomized, placebo-controlled
  189. (1995). Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. doi
  190. (1989). Reid DB (200 Modification of general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic detailer). doi
  191. (2002). Researching outcomes of educational interventions. Initial formation of unbiased groups is most important issue in randomised controlled trials.
  192. (2002). Researching outcomes of educational interventions. Theory e diffusion of innovations in health care: the science in medicine.' doi
  193. (1996). Results of an office-based training program in clinical breast examinatio primary care physicians.
  194. (1995). Reviews of Effectiveness [database on line]. doi
  195. (1986). Risk factors for acquiri pneumococcal infections.
  196. (1992). Risk factors for nosocomial pneumoni the elderly.
  197. (1994). Risk factors for pneumonia in the elderly. doi
  198. (1996). rofiling on utilization. Meta-analysis of randomized clinical trials.
  199. (1985). ronic obstructive pulmonary disease? Qual.Health Care 8, 92-98. ) de vaccines.
  200. S 282and diabetic patients? A randomised controlled trial in general practices in east London. doi
  201. S polysaccharide vaccine. N.Engl.J Med. 325, 1453-1460. pneumococcal vaccine for patients at high risk of serious pneumococcal infections. doi
  202. Safran DG Roland MO (2001b) Identifying predictors of high quality care in English gen practice: observational study. doi
  203. (1993). Sculpting the learning organization: lessons in the and science of systematic change.' doi
  204. sed in general practice. BMJ 314, 1094-1098. ococcal vaccine campaign based in general practice. Authors' reply. BMJ 315, 816. fluenza vaccination.
  205. (1997). Should we pay the patient? Review of financ incentives to enhance patient complianc doi
  206. (1997). Side effects associated with
  207. (1996). Side effects associated with influenza vaccination in healthy
  208. (1994). Single and combined strategies for implementing changes in primary care: a literature review. doi
  209. (1993). smoking: toward an integrative model of change. J Consult Clin.Psychol. 51, 390-Proctor M
  210. (1982). Statistics for social scientists.' (Harper & Row: London) ve disease prevention. doi
  211. (1998). Strategies for changing pulic behaviour.' (Free Press:
  212. (1981). Streptococcus pneumoniae polysaccharide vaccine: age and dose response safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vac 287Holden doi
  213. (1997). Streptococcus pneumoniae: serotypes, Gianino CA, Corazzini K, Tseng WT,
  214. (1998). students regarding pulmonary prevention. Chest 114, 1193-1198. rsies Spira JL (2002) GPs mustn't be dismayed about grasp of cognitive therapy.
  215. (1977). Studies of respiratory function in volunteers given live influenza virus vaccine.
  216. (1995). Study of the effectiveness of influenza vaccination in the elderly in the epidemic of Fleming doi
  217. (1980). Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines.' (National Institutes of Health Publication DABVDP-12-84. Contract No 1A13257,
  218. (2001). Systematic reviews in health care: 323, 101-105. Lancet 340, 1036-1037. health care teams associated with successful quality improvement of diabetes care: a qualitative study.
  219. (1993). Systemic vasculitis following influenza vaccination--report of 3 ca
  220. (1997). Table 23 Influenza vaccine uptake, Minster Practice 1997-1999 Criteria Standards
  221. th a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community.
  222. (2002). Th University, Leicester) care practice: behavioural, organisational and scientific processes.' (De Montfort University, Leicester) 283Fleming DM
  223. (1990). The adult learner : a neglected species.' doi
  224. (2001). The behavior of organisms an experimental analysis.' doi
  225. (1995). The effectiveness of vaccination against influenza in healthy, working adults. N.Engl.J Med. 333, 889-893. attitudes, and behavior among high- risk outpatients. doi
  226. (2002). The effects of manual paper reminders on professional practice and health care outcomes: a systematic review of randomised controlled trials. Final project repor Yassi
  227. (1994). The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990-- ethnic ucational activities on physician performance or health care outcomes.
  228. (2001). The impact of record scattering on the measurement of immunization coverage. doi
  229. (2001). The need for caution in interpreting high quality systematic reviews. BMJ 323, 681-684. Hulsc guidelines and improving preventive care. doi
  230. (1998). The new NHS: a national framework for assessing adults against influenza.
  231. the older adult: results of a randomized cohort study.
  232. (1997). The provision of influenza vaccine to patients over 65 years by general practitioners.
  233. (2000). The r PA (2002) Use of recommended vaccinations for adults by Swiss primary care physicians.
  234. (1992). The role of age in susceptibility to pneumococcal inf doi
  235. (1994). tion in elderly individuals. A randomized doubleblind placebo-controlled trial. JAMA 272, 1661-1665. . Serogroups/types and antibiotic resistance of referred isolates of Streptococcus pneumoniae:
  236. (1995). to a postal questionnaire from a general practice and a research unit.
  237. (2001). Translating evidence into practice: pursuing perfection in pneumococcal vaccination in a rural community.
  238. (1992). Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, doi
  239. (1998). Understanding change in primary
  240. (1998). Understanding medical systems. doi
  241. (1989). Uptake of influenza vaccination by patients wit serious ca 290Kyaw
  242. (1996). Use of antivirals in influenza in the elderly: prophylaxis and therapy. doi
  243. (2000). Use of standing orders program to increase adult vaccination rates: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Chakraverty P
  244. (1997). Vaccination levels among Hispanics and nonCenters for Disease Control and Prevention
  245. (1994). Vaccine immune response and side effects with the use of acetaminophen with influenza vaccine.
  246. (1984). Vaccine-drug interactions. doi
  247. (1991). Validity of clinical diagnos Requejo HIZ
  248. (2000). Validity of final examinations in undergraduate medical van Eijk doi
  249. ving in the community. doi
  250. (1999). Why don't physicians fo
  251. (2001). Why general practitioners do not implement evidence: qualitative study. doi
  252. (2000). Windows: a guide for social scientists.' (Routledge: London) 277Buchwald
  253. (1991). Words without action? The production, dissemination, and impact of Long CE,
  254. years: AAFP leads the nation in influenza vaccine policy.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.